STOCK TITAN

IBM (IBM) details C$2.75B Canadian-dollar notes and new underwriting deal

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

International Business Machines Corporation filed a current report to add key debt-offering documents into its existing Form S-3 shelf registration (No. 333-276739, effective January 29, 2024). The filing covers exhibits related to C$2,750,000,000 aggregate principal amount of debt securities (the “Notes”) offered by means of a prospectus supplement.

IBM lists an underwriting agreement dated August 10, 2026 with CIBC World Markets, RBC Dominion Securities, Scotia Capital and TD Securities as representatives of the underwriters, along with forms of a 4.100% Note due 2030 and a 4.750% Note due 2034. It also includes the related legal opinion and consent from a company vice president and assistant general counsel, plus the cover-page Inline XBRL data file.

Positive

  • None.

Negative

  • None.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Aggregate principal amount of Notes C$2,750,000,000 Debt securities of the registrant incorporated into Form S-3
Coupon rate Note due 2030 4.100% Form of 4.100% Note due 2030 filed as Exhibit 4.1
Coupon rate Note due 2034 4.750% Form of 4.750% Note due 2034 filed as Exhibit 4.2
Shelf registration number 333-276739 Form S-3 effective January 29, 2024
Filing date of underwriting agreement August 10, 2026 Date of Underwriting Agreement with Canadian underwriters
aggregate principal amount financial
"relating to C$2,750,000,000 aggregate principal amount of debt securities"
The aggregate principal amount is the total amount of money borrowed through a bond or loan that the borrower promises to repay. It’s like the original price tag on a loan or bond, showing how much money is involved in the deal. This number matters because it indicates the size of the debt and helps investors understand the scale of the borrowing.
prospectus supplement regulatory
"The Notes were offered by means of a prospectus supplement"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Registration Statement regulatory
"incorporate by reference into Registration Statement No. 333-276739 on Form S-3"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
Underwriting Agreement financial
"Underwriting Agreement dated August 10, 2026 among International Business Machines"
An underwriting agreement is a contract where a company selling new stocks or bonds hires financial firms to buy those securities and resell them to investors. It matters because the agreement sets the offering price, number of securities, fees and which party bears the risk if sales fall short—think of it as a promise that the sale will happen and a roadmap investors can use to understand how the new securities reach the market.
Inline XBRL technical
"Interactive Data File because its XBRL tags are embedded within the Inline XBRL document"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

What did IBM (IBM) disclose about new debt securities in this 8-K?

IBM disclosed exhibits related to C$2,750,000,000 aggregate principal amount of debt securities. These Notes were offered via a prospectus supplement and are incorporated by reference into IBM’s existing Form S-3 shelf registration statement effective January 29, 2024.

What specific notes are referenced in IBM (IBM)’s August 10, 2026 filing?

The filing references forms of a 4.100% Note due 2030 and a 4.750% Note due 2034. These instruments are part of the C$2,750,000,000 aggregate principal amount of debt securities, with their forms filed as Exhibits 4.1 and 4.2.

Which underwriters are involved in IBM (IBM)’s C$2.75 billion notes offering?

IBM filed an underwriting agreement with CIBC World Markets Inc., RBC Dominion Securities Inc., Scotia Capital Inc. and TD Securities Inc.. These firms act as the representatives of the underwriters for the C$2,750,000,000 aggregate principal amount of Notes referenced in the report.

How does this 8-K relate to IBM (IBM)’s Form S-3 shelf registration?

The report incorporates specific exhibits into Registration Statement No. 333-276739 on Form S-3, effective January 29, 2024. It adds the underwriting agreement, forms of the 2030 and 2034 notes, and the related legal opinion and consent regarding the Notes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0000051143 0000051143 2026-08-10 2026-08-10 0000051143 us-gaap:CommonStockMember exch:XNYS 2026-08-10 2026-08-10 0000051143 us-gaap:CommonStockMember exch:XCHI 2026-08-10 2026-08-10 0000051143 ibm:Notes0.300PercentDue2026Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes1.250PercentDue2027Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes3.375PercentDue2027Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes0.300PercentDue2028Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes1.750PercentDue2028Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes1.500PercentDue2029Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes0.875PercentDue2030Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes2.900PercentDue2030Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes1.750PercentDue2031Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes3.000PercentDue2031Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes3.625PercentDue2031Member exch:XNYS 2026-08-10 2026-08-10 0000051143 exch:XNYS ibm:Notes0.650PercentDue2032Member 2026-08-10 2026-08-10 0000051143 ibm:Notes3.150PercentDue2033Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes3.450PercentDue2034Member exch:XNYS 2026-08-10 2026-08-10 0000051143 exch:XNYS ibm:Notes1.250PercentDue2034Member 2026-08-10 2026-08-10 0000051143 ibm:Notes3.750PercentDue2035Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes3.450PercentDue2037Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes3.850PercentDue2038Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes4.875PercentDue2038Member exch:XNYS 2026-08-10 2026-08-10 0000051143 exch:XNYS ibm:Notes1.200PercentDie2040Member 2026-08-10 2026-08-10 0000051143 ibm:Notes4.000PercentDue2043Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Notes3.800PercentDue2045Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:FloatingRateNotesdue2028Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Debentures6.22PercentDue2027Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Debentures6.50PercentDue2028Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Debentures5.875PercentDue2032Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Debentures7.00PercentDue2045Member exch:XNYS 2026-08-10 2026-08-10 0000051143 ibm:Debentures7.125PercentDue2096Member exch:XNYS 2026-08-10 2026-08-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934 

 

Date of Report: August 10, 2026

(Date of earliest event reported)

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

(Exact name of registrant as specified in its charter)

 

New York   1-2360   13-0871985
(State of Incorporation)   (Commission File Number)   (IRS employer Identification No.)

 

One New Orchard Road

   
Armonk, New York   10504
(Address of principal executive offices)   (Zip Code)

 

914-499-1900

(Registrant’s telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Capital stock, par value $.20 per share   IBM   New York Stock Exchange
    NYSE Texas
0.300% Notes due 2026   IBM 26B   New York Stock Exchange
1.250% Notes due 2027   IBM 27B   New York Stock Exchange
3.375% Notes due 2027   IBM 27F   New York Stock Exchange
0.300% Notes due 2028   IBM 28B   New York Stock Exchange
1.750% Notes due 2028   IBM 28A   New York Stock Exchange
1.500% Notes due 2029   IBM 29   New York Stock Exchange
0.875% Notes due 2030   IBM 30A   New York Stock Exchange
2.900% Notes due 2030   IBM 30C   New York Stock Exchange
1.750% Notes due 2031   IBM 31   New York Stock Exchange
3.000% Notes due 2031   IBM 31A   New York Stock Exchange
3.625% Notes due 2031   IBM 31B   New York Stock Exchange
0.650% Notes due 2032   IBM 32A   New York Stock Exchange
3.150% Notes due 2033   IBM 33A   New York Stock Exchange
3.450% Notes due 2034   IBM 34A   New York Stock Exchange
1.250% Notes due 2034   IBM 34   New York Stock Exchange
3.750% Notes due 2035   IBM 35   New York Stock Exchange
3.450% Notes due 2037   IBM 37   New York Stock Exchange
3.850% Notes due 2038   IBM 38B   New York Stock Exchange
4.875% Notes due 2038   IBM 38   New York Stock Exchange
1.200% Notes due 2040   IBM 40   New York Stock Exchange
4.000% Notes due 2043   IBM 43   New York Stock Exchange
3.800% Notes due 2045   IBM 45A   New York Stock Exchange
Floating Rate Notes due 2028   IBM 28E   New York Stock Exchange
6.22% Debentures due 2027   IBM 27   New York Stock Exchange
6.50% Debentures due 2028   IBM 28   New York Stock Exchange
5.875% Debentures due 2032   IBM 32D   New York Stock Exchange
7.00% Debentures due 2045   IBM 45   New York Stock Exchange
7.125% Debentures due 2096   IBM 96   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Financial Statements and Exhibits.

 

This Current Report on Form 8-K is being filed to incorporate by reference into Registration Statement No. 333-276739 on Form S-3, effective January 29, 2024, the documents included as (1) Exhibits 1.1, 4.1 and 4.2 relating to C$2,750,000,000 aggregate principal amount of debt securities of the Registrant (the “Notes”) and (2) Exhibits 5.1 and 23.1 regarding the Notes. The Notes were offered by means of a prospectus supplement.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
No.
  Description of Exhibit
1.1   Underwriting Agreement dated August 10, 2026 among International Business Machines Corporation and CIBC World Markets Inc., RBC Dominion Securities Inc., Scotia Capital Inc. and TD Securities Inc., as the Representatives of the Underwriters
4.1   Form of 4.100% Note due 2030
4.2   Form of 4.750% Note due 2034
5.1   Opinion of Jane P. Edwards, Vice President, Assistant General Counsel and Secretary regarding the Notes
23.1   Consent of Jane P. Edwards, Vice President, Assistant General Counsel and Secretary (included in Exhibit 5.1)
104   Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

  

IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

Date: August 14, 2026  
   
  By: /s/ Brien Wierzchowski
    Brien Wierzchowski
    Vice President and Treasurer

 

 

 

Filing Exhibits & Attachments

8 documents